187 related articles for article (PubMed ID: 7528219)
21. Binding of anisoylated Lys-plasminogen streptokinase activator complex to cells in culture.
Vasudevan J; Humphries JE; Gonias SL
Thromb Haemost; 1993 Apr; 69(4):370-4. PubMed ID: 8388580
[TBL] [Abstract][Full Text] [Related]
22. Identification of molecular forms of plasminogen and plasmin-inhibitor complexes in urokinase-activated human plasma.
Müllertz S; Thorsen S; Sottrup-Jensen L
Biochem J; 1984 Oct; 223(1):169-77. PubMed ID: 6208893
[TBL] [Abstract][Full Text] [Related]
23. The endothelial cell tissue plasminogen activator receptor. Specific interaction with plasminogen.
Hajjar KA
J Biol Chem; 1991 Nov; 266(32):21962-70. PubMed ID: 1657983
[TBL] [Abstract][Full Text] [Related]
24. Binding and activation of plasminogen at the surface of Staphylococcus aureus. Increase in affinity after conversion to the Lys form of the ligand.
Kuusela P; Saksela O
Eur J Biochem; 1990 Nov; 193(3):759-65. PubMed ID: 1701146
[TBL] [Abstract][Full Text] [Related]
25. Receptor for plasmin on human carcinoma cells.
Burtin P; Fondaneche MC
J Natl Cancer Inst; 1988 Jul; 80(10):762-5. PubMed ID: 2838642
[TBL] [Abstract][Full Text] [Related]
26. Specific inhibition of the activity of the urokinase receptor-mediated cell-surface plasminogen activation system by suramin.
Ellis V; Danø K
Biochem J; 1993 Dec; 296 ( Pt 2)(Pt 2):505-10. PubMed ID: 8257443
[TBL] [Abstract][Full Text] [Related]
27. Binding of plasminogen to Neisseria meningitidis and Neisseria gonorrhoeae and formation of surface-associated plasmin.
Ullberg M; Kuusela P; Kristiansen BE; Kronvall G
J Infect Dis; 1992 Dec; 166(6):1329-34. PubMed ID: 1385549
[TBL] [Abstract][Full Text] [Related]
28. Nonlysine-analog plasminogen modulators promote autoproteolytic generation of plasmin(ogen) fragments with angiostatin-like activity.
Ohyama S; Harada T; Chikanishi T; Miura Y; Hasumi K
Eur J Biochem; 2004 Feb; 271(4):809-20. PubMed ID: 14764098
[TBL] [Abstract][Full Text] [Related]
29. Thrombin decreases the urokinase receptor and surface-localized fibrinolysis in cultured endothelial cells.
Li XN; Varma VK; Parks JM; Benza RL; Koons JC; Grammer JR; Grenett H; Tabengwa EM; Booyse FM
Arterioscler Thromb Vasc Biol; 1995 Mar; 15(3):410-9. PubMed ID: 7749851
[TBL] [Abstract][Full Text] [Related]
30. Borrelia burgdorferi binds plasminogen, resulting in enhanced penetration of endothelial monolayers.
Coleman JL; Sellati TJ; Testa JE; Kew RR; Furie MB; Benach JL
Infect Immun; 1995 Jul; 63(7):2478-84. PubMed ID: 7790059
[TBL] [Abstract][Full Text] [Related]
31. Alveolar macrophage urokinase receptors localize enzyme activity to the cell surface.
Chapman HA; Bertozzi P; Sailor LZ; Nusrat AR
Am J Physiol; 1990 Dec; 259(6 Pt 1):L432-8. PubMed ID: 2175557
[TBL] [Abstract][Full Text] [Related]
32. Kinetics of reciprocal pro-urokinase/plasminogen activation--stimulation by a template formed by the urokinase receptor bound to poly(D-lysine).
Petersen LC
Eur J Biochem; 1997 Apr; 245(2):316-23. PubMed ID: 9151959
[TBL] [Abstract][Full Text] [Related]
33. Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro.
Lacroix R; Sabatier F; Mialhe A; Basire A; Pannell R; Borghi H; Robert S; Lamy E; Plawinski L; Camoin-Jau L; Gurewich V; Angles-Cano E; Dignat-George F
Blood; 2007 Oct; 110(7):2432-9. PubMed ID: 17606760
[TBL] [Abstract][Full Text] [Related]
34. Macrophage formation of angiostatin during inflammation. A byproduct of the activation of plasminogen.
Falcone DJ; Khan KM; Layne T; Fernandes L
J Biol Chem; 1998 Nov; 273(47):31480-5. PubMed ID: 9813061
[TBL] [Abstract][Full Text] [Related]
35. Urokinase plasminogen activator induces human smooth muscle cell migration and proliferation via distinct receptor-dependent and proteolysis-dependent mechanisms.
Stepanova V; Mukhina S; Köhler E; Resink TJ; Erne P; Tkachuk VA
Mol Cell Biochem; 1999 May; 195(1-2):199-206. PubMed ID: 10395084
[TBL] [Abstract][Full Text] [Related]
36. Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.
Barnathan ES; Kuo A; Rosenfeld L; Karikó K; Leski M; Robbiati F; Nolli ML; Henkin J; Cines DB
J Biol Chem; 1990 Feb; 265(5):2865-72. PubMed ID: 2154462
[TBL] [Abstract][Full Text] [Related]
37. Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase.
Hajjar KA; Hamel NM
J Biol Chem; 1990 Feb; 265(5):2908-16. PubMed ID: 2154465
[TBL] [Abstract][Full Text] [Related]
38. Differential inhibition of soluble and cell surface receptor-bound single-chain urokinase by plasminogen activator inhibitor type 2. A potential regulatory mechanism.
Schwartz BS
J Biol Chem; 1994 Mar; 269(11):8319-23. PubMed ID: 7907591
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of cell surface receptor-bound plasmin by alpha 2-antiplasmin and alpha 2-macroglobulin.
Hall SW; Humphries JE; Gonias SL
J Biol Chem; 1991 Jul; 266(19):12329-36. PubMed ID: 1712017
[TBL] [Abstract][Full Text] [Related]
40. The cell biology of the plasminogen system.
Plow EF; Herren T; Redlitz A; Miles LA; Hoover-Plow JL
FASEB J; 1995 Jul; 9(10):939-45. PubMed ID: 7615163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
